stockportfolio.pro
Stocks / EYPT vs SDGR
EYPT vs SDGR
EyePoint, Inc. and Schrödinger, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| EyePoint, Inc. (EYPT) | Schrödinger, Inc. (SDGR) | |
|---|---|---|
| Market cap | $1.0B | $1.1B |
| Revenue (latest FY) | $31.37M | $255.87M |
| Net income (latest FY) | $-231.96M | $-103.27M |
| Revenue growth (5y CAGR) | -1.8% | 18.8% |
| Net margin | -739.4% | -40.4% |
| Return on equity | -75.8% | -28.4% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 1 |
| Positive free cash flow | No | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open EYPT — free Open SDGR — freeFrequently asked questions
Which is bigger, EYPT or SDGR?
Schrödinger, Inc. is larger by market capitalization — $1.1B versus $1.0B.
Which grows faster, EYPT or SDGR?
Over the last five fiscal years, Schrödinger, Inc. grew revenue faster — 18.8%/yr versus -1.8%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.